FOR IMMEDIATE RELEASE
MESA, Ariz. — August 3, 2023
Just published today in Taylor & Francis’s prestigious journal, “Human Vaccines & Immunotherapeutics,” is a groundbreaking study on the safety of COVID19 mRNA vaccines. The study, the first of its kind on this subject, used statistical analysis to compare the risk of death and specifically the risk of death from cardiac causes (heart attacks, heart inflammation, etc. etc.) in the short period of time following the administration of the COVID19 mRNA vaccination on over 750,000 individuals. The study found a significant increase in cardiac-related deaths following the administration of the vaccinations. This connection was previously proposed by Dr. Joseph Ladapo, and was disputed by CDC officials including the commissioner (Robert M. Califf, MD) and director (Rochelle P. Walensky, MD). The study was led by Dr. Greg Marchand MD. Full Study: https://www.tandfonline.com/doi/full/10.1080/21645515.2023.2230828
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###







